欧州のために回復力のある医療システムを再構築する。

イギリスの医学誌「ランセット(The Lancet)」は2021年10月07日に、この度、Lancet Regional Health - Europe Seriesの「Rebuilding Resilient Health Systems for Europe(欧州のために回復力のある医療システムを再構築する)」をお届けしますとメールで配信してきた。

これは医学雑誌が贈るテーマではない。

広大である。

https://time-az.com/main/detail/75355

COVID-19パンデミックは、世界の公衆衛生とイノベーションを中心に据え、健康な社会の門番としての不可欠な役割を明らかにした。すべての国の保健システムはパンデミックによって緊張しており、ほとんどの保健システムがパンデミックの圧力の下で適応し、革新するためには、大幅な見直しが必要であり、また、気候変動の脅威を包括的に考慮すると、健康の安全性にも影響する。

このような背景から、The Lancet Regional Health - Europeは、公衆衛生(public health)、グローバルヘルス(global health)、倫理(ethics)、経済政策(economic policies)、法律(laws)、規制機関(regulatory bodies)など、さまざまな分野の専門家による11本の論文をオープンアクセスで発表した。このシリーズでは、ヨーロッパの医療システムが形成されている基本的な柱、既存の構造にどのような変化が必要か、ヨーロッパの医療システムをより強靭なものにするためにはどのような新しい基盤を構築しなければならないかを、多層的なアプローチで明らかにしている。

また、2021年10月21日に開催されるLancet Webinarでは、The Lancet Regional Health - Europeの編集長であるプージャ・ジャ(Pooja Jha)が、シリーズの著者数名とシリーズの論文について議論する。

Speakers

Pooja Jha
Editor-in-Chief
The Lancet Regional Health – Europe
Pooja Jha joined the Lancet as the Editor-in-Chief of The Lancet Regional Health – Europe in Oct 2020 in the Lancet Munich office and launched the journal in Feb 2021. Pooja is committed to represent voices from all corners of Europe and diversity in topic—that will advance, influence and challenge clinical practice and public health, with the goal of improving health outcomes and narrowing health inequality gaps in the region. Prior to this role, Pooja worked at Nature Research in Berlin as an editor of Nature Metabolism and contributed to the launch of the journal since 2018. Pooja has a BSc degree in Chemistry, Botany, Zoology, and a MSc degree in Medical Molecular Biology and Human Genetics from India. She obtained her PhD in Molecular Medicine at the Medical University of Graz, Austria, which was followed by her postdoctoral research in systems genetics at EPFL, Switzerland.

Mark Jit
Professor of vaccine epidemiology
London School of Hygiene & Tropical Medicine
Mark Jit is a Professor of vaccine epidemiology at the London School of Hygiene & Tropical Medicine and visiting professor at the School of Public Health, University of Hong Kong. His research group focuses on epidemiological and economic analyses of infectious disease interventions such as vaccination to support evidence-based public health decision making. This work has influenced many of the major changes to immunisation policy in the UK and globally. Since 2020, much of his work has focused on understanding the COVID-19 pandemic and ways to mitigate it.

Marion Koopmans
Professor, Department of Viroscience
Erasmus Medical Center, Rotterdam
Marion Koopmans is a Professor of Virology at Erasmus MC (Rotterdam, The Netherlands). She works on global population level impact of rapidly spreading zoonotic virus infections, with special emphasis on foodborne transmission. Her research focuses on unravelling the modes of transmission of viruses among animals and between animals and humans, and the use of pathogenic genomic information to unravel these pathways. She is scientific coordinator of COMPARE, a large H2020 funded project exploring the potential uses of next generation sequencing techniques for outbreak detection and tracking. She is also co-PI in the FP7 funded PREPARE project aimed at building a pan-European operational network for rapid and large-scale European clinical research in response to infectious disease outbreaks with epidemic potential. She is Director of the WHO Collaborating Centre for emerging infectious diseases at Erasmus, and Scientific Director “Emerging infectious diseases” of the Netherlands Centre for One Health. She has received the Infectious Disease Award of the Dutch Association for Infectious Diseases and is the recipient of the Stevin Premium 2018. In 2019, she became a member of the KNAW (Royal Dutch Academy of Sciences).

Marco Cavaleri
Head of Biological Health Threats and Vaccines Strategy
European Medicines Agency (EMA)
Marco Cavaleri is Head of Office, Biological Health Threats and Vaccines Strategy at the EMA. He is the Chair of EMA COVID Task force and responsible for EMA activities for emergent pathogens, vaccines and AMR. He is a pharmacologist by training who spent several years in industry in R&D mainly in the area of anti-infectives covering different positions in preclinical and clinical development. In 2005 he joined the EMEA as Scientific Administrator in the Scientific Advice and Orphan Drugs Sector, specifically being in charge of anti-infectives and vaccines scientific advice procedures. In 2009 he was appointed as Head of Section for Anti-infectives and vaccines in the Safety & Efficacy Sector, Human Medicines Development and Evaluation Unit.

Katrina Perehudoff
Senior Research Fellow and Co-Director of the Law Center for Health and Life
University of Amsterdam
Katrina Perehudoff is a health scientist and legal scholar with over a decade of experience in pharmaceutical policy. Her research examines the tensions between legal norms impacting on pharmaceuticals, and the effect of law and policy on access to medicines. She is a Senior Research Fellow and Co-Director of the Law Center for Health and Life at the University of Amsterdam (Netherlands). She is also affiliated with the Amsterdam Centre for European Law & Governance (ACELG), the Amsterdam Institute of Global Health & Development (AIGHD), the WHO Collaborating Centre for Governance, Accountability, and Transparency in the Pharmaceutical Sector (University of Toronto), and Medicines Law & Policy. Katrina is an Advisory Board Member to the Pharmaceutical Accountability Foundation and Chair of the European Association of Health Action International.

Ana Marušić
Professor of Anatomy and Chair of the Department of Research in Biomedicine and Health
University of Split School of Medicine, Split, Croatia
Ana Marušić is a Professor of Anatomy and Chair of the Department of Research in Biomedicine and Health at the University of Split School of Medicine, Split, Croatia. She is an Honorary Professor at the University of Edinburgh in the UK and Co-Editor in Chief of the Journal of Global Health. She is on the Steering Group of the EQUATOR Network and is the Co-Chair of the Cochrane Scientific Committee. She was the president of several editorial organizations: European Association of Science Editors (EASE), Council of Science Editors (CSE), and World Association of Medical Editors (WAME), and is a former member of the International Committee of Medical Journal Editors (ICMJE). She currently serves on the Council of the Publication Ethics (COPE). Prof. Marušić has more than 300 peer-reviewed publications and was heavily involved with creating the policy of mandatory registration of clinical trials in public registries which helped change the legal regulation of clinical trials worldwide.

Jan C. Semenza
Research Associate, Heidelberg Institute of Global Health
University of Heidelberg
Jan C. Semenza has served as an Epidemic Intelligence Service Officer at the US Centers for Disease Control and Prevention (CDC) in 1995 when a record-breaking heat wave claimed the lives of more than 700 individuals in Chicago. He led the US CDC response to this event and elucidated the underlying environmental, societal, and behavioural risk factors for heat-related mortality. He was subsequently awarded a Certificate of Commendation by the City of Chicago for this investigation. He also worked internationally on a number of public health issues in Uzbekistan, Sudan, Egypt, Denmark, Brazil, and Haiti. He was a faculty member at UC Berkeley, UC Irvine, Oregon Health and Science University, and at Portland State University where he taught in the Oregon Master Program of Public Health. He lead the work on environmental and climatic drivers of infectious disease transmission at the European Centre for Disease Prevention and Control (ECDC), based in Stockholm, Sweden. Currently, he is associated with the Heidelberg Institute of Global Health, at the University of Heidelberg in Germany.

皆様のご参加を心よりお待ちしております。